Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1996 2
1997 2
2000 1
2001 1
2003 2
2004 3
2005 1
2006 2
2007 3
2008 2
2009 1
2010 3
2011 1
2012 2
2014 3
2015 2
2016 1
2017 6
2018 6
2019 5
2020 19
2021 19
2022 11
2023 9
2024 5
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

102 results

Results by year

Filters applied: . Clear all
Page 1
Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper.
Jutel M, Agache I, Zemelka-Wiacek M, Akdis M, Chivato T, Del Giacco S, Gajdanowicz P, Gracia IE, Klimek L, Lauerma A, Ollert M, O'Mahony L, Schwarze J, Shamji MH, Skypala I, Palomares O, Pfaar O, Torres MJ, Bernstein JA, Cruz AA, Durham SR, Galli SJ, Gómez RM, Guttman-Yassky E, Haahtela T, Holgate ST, Izuhara K, Kabashima K, Larenas-Linnemann DE, von Mutius E, Nadeau KC, Pawankar R, Platts-Mills TAE, Sicherer SH, Park HS, Vieths S, Wong G, Zhang L, Bilò MB, Akdis CA. Jutel M, et al. Among authors: chivato t. Allergy. 2023 Nov;78(11):2851-2874. doi: 10.1111/all.15889. Epub 2023 Oct 10. Allergy. 2023. PMID: 37814905
Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis.
Bousquet J, Melén E, Haahtela T, Koppelman GH, Togias A, Valenta R, Akdis CA, Czarlewski W, Rothenberg M, Valiulis A, Wickman M, Akdis M, Aguilar D, Bedbrook A, Bindslev-Jensen C, Bosnic-Anticevich S, Boulet LP, Brightling CE, Brussino L, Burte E, Bustamante M, Canonica GW, Cecchi L, Celedon JC, Chaves Loureiro C, Costa E, Cruz AA, Erhola M, Gemicioglu B, Fokkens WJ, Garcia-Aymerich J, Guerra S, Heinrich J, Ivancevich JC, Keil T, Klimek L, Kuna P, Kupczyk M, Kvedariene V, Larenas-Linnemann DE, Lemonnier N, Lodrup Carlsen KC, Louis R, Makela M, Makris M, Maurer M, Momas I, Morais-Almeida M, Mullol J, Naclerio RN, Nadeau K, Nadif R, Niedoszytko M, Okamoto Y, Ollert M, Papadopoulos NG, Passalacqua G, Patella V, Pawankar R, Pham-Thi N, Pfaar O, Regateiro FS, Ring J, Rouadi PW, Samolinski B, Sastre J, Savouré M, Scichilone N, Shamji MH, Sheikh A, Siroux V, Sousa-Pinto B, Standl M, Sunyer J, Taborda-Barata L, Toppila-Salmi S, Torres MJ, Tsiligianni I, Valovirta E, Vandenplas O, Ventura MT, Weiss S, Yorgancioglu A, Zhang L, Abdul Latiff AH, Aberer W, Agache I, Al-Ahmad M, Alobid I, Ansotegui IJ, Arshad SH, Asayag E, Barbara C, Baharudin A, Battur L, Bennoor KS, Berghea EC, Bergmann KC, B… See abstract for full author list ➔ Bousquet J, et al. Among authors: chivato t. Allergy. 2023 May;78(5):1169-1203. doi: 10.1111/all.15679. Epub 2023 Apr 10. Allergy. 2023. PMID: 36799120 Free article. Review.
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma.
Agache I, Beltran J, Akdis C, Akdis M, Canelo-Aybar C, Canonica GW, Casale T, Chivato T, Corren J, Del Giacco S, Eiwegger T, Firinu D, Gern JE, Hamelmann E, Hanania N, Mäkelä M, Hernández-Martín I, Nair P, O'Mahony L, Papadopoulos NG, Papi A, Park HS, Pérez de Llano L, Posso M, Rocha C, Quirce S, Sastre J, Shamji M, Song Y, Steiner C, Schwarze J, Alonso-Coello P, Palomares O, Jutel M. Agache I, et al. Among authors: chivato t. Allergy. 2020 May;75(5):1023-1042. doi: 10.1111/all.14221. Epub 2020 Feb 24. Allergy. 2020. PMID: 32034960
EAACI Biologicals Guidelines-Recommendations for severe asthma.
Agache I, Akdis CA, Akdis M, Canonica GW, Casale T, Chivato T, Corren J, Chu DK, Del Giacco S, Eiwegger T, Flood B, Firinu D, Gern JE, Hamelmann E, Hanania N, Hernández-Martín I, Knibb R, Mäkelä M, Nair P, O'Mahony L, Papadopoulos NG, Papi A, Park HS, Pérez de Llano L, Pfaar O, Quirce S, Sastre J, Shamji M, Schwarze J, Palomares O, Jutel M. Agache I, et al. Among authors: chivato t. Allergy. 2021 Jan;76(1):14-44. doi: 10.1111/all.14425. Epub 2020 Aug 10. Allergy. 2021. PMID: 32484954
Anwendung von Biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen Covid-19-Pandemiea, b, c: Positionspapier des Ärzteverbands Deutscher Allergologen (AeDA)A, der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI)B, der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C, der Österreichischen Gesellschaft für Allergologie und Immunologie (ÖGAI)D, der Luxemburgischen Gesellschaft für Allergologie und Immunologie (LGAI)E, der Österreichischen Gesellschaft für Pneumologie (ÖGP)F in Kooperation mit der deutschen, österreichischen, und schweizerischen ARIA-GruppeG und der Europäischen Akademie für Allergologie und Klinische Immunologie (EAACI)H.
Klimek L, Pfaar O, Worm M, Eiwegger T, Hagemann J, Ollert M, Untersmayr E, Hoffmann-Sommergruber K, Vultaggio A, Agache I, Bavbek S, Bossios A, Casper I, Chan S, Chatzipetrou A, Vogelberg C, Firinu D, Kauppi P, Kolios A, Kothari A, Matucci A, Palomares O, Szépfalusi Z, Pohl W, Hötzenecker W, Rosenkranz A, Bergmann KC, Bieber T, Buhl R, Buters J, Darsow U, Keil T, Kleine-Tebbe J, Lau S, Maurer M, Merk H, Mösges R, Saloga J, Staubach P, Jappe U, Rabe C, Rabe U, Vogelmeier C, Biedermann T, Jung K, Schlenter W, Ring J, Chaker A, Wehrmann W, Becker S, Freudelsperger L, Mülleneisen N, Nemat K, Czech W, Wrede H, Brehler R, Fuchs T, Tomazic PV, Aberer W, Fink Wagner A, Horak F, Wöhrl S, Niederberger-Leppin V, Pali-Schöll I, Roller-Wirnsberger R, Spranger O, Valenta R, Akdis M, Matricardi PM, Spertini F, Khaltaev N, Michel JP, Nicod L, Schmid-Grendelmeier P, Idzko M, Hamelmann E, Jakob T, Werfel T, Wagenmann M, Taube C, Jensen-Jarolim E, Korn S, Hentges F, Schwarze J, O Mahony L, Knol E, Del Giacco S, Chivato T, Bousquet J, Zuberbier T, Akdis C, Jutel M. Klimek L, et al. Among authors: chivato t. Allergo J. 2020;29(4):14-27. doi: 10.1007/s15007-020-2553-y. Epub 2020 Jun 24. Allergo J. 2020. PMID: 32546898 Free PMC article. Review. German. No abstract available.
EAACI Biologicals Guidelines-Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12-17 years old.
Agache I, Akdis CA, Akdis M, Brockow K, Chivato T, Del Giacco S, Eiwegger T, Eyerich K, Giménez-Arnau A, Gutermuth J, Guttman-Yassky E, Maurer M, Ogg G, Ong PY, O'Mahony L, Schwarze J, Warner A, Werfel T, Palomares O, Jutel M. Agache I, et al. Among authors: chivato t. Allergy. 2022 Jan;77(1):17-38. doi: 10.1111/all.15030. Epub 2021 Aug 8. Allergy. 2022. PMID: 34324716
The Allergic Rhinitis and Its Impact on Asthma (ARIA) Approach of Value-Added Medicines: As-Needed Treatment in Allergic Rhinitis.
Bousquet J, Toumi M, Sousa-Pinto B, Anto JM, Bedbrook A, Czarlewski W, Valiulis A, Ansotegui IJ, Bosnic-Anticevich S, Brussino L, Canonica GW, Cecchi L, Cherrez-Ojeda I, Chivato T, Costa EM, Cruz AA, Del Giacco S, Fonseca JA, Gemicioglu B, Haahtela T, Ivancevich JC, Jutel M, Kaidashev I, Klimek L, Kvedariene V, Kuna P, Larenas-Linnemann DE, Lipworth B, Morais-Almeida M, Mullol J, Papadopoulos NG, Patella V, Pham-Thi N, Regateiro FS, Rouadi PW, Samolinski B, Sheikh A, Taborda-Barata L, Ventura MT, Yorgancioglu A, Zidarn M, Zuberbier T. Bousquet J, et al. Among authors: chivato t. J Allergy Clin Immunol Pract. 2022 Nov;10(11):2878-2888. doi: 10.1016/j.jaip.2022.07.020. Epub 2022 Aug 4. J Allergy Clin Immunol Pract. 2022. PMID: 35934308
Adherence to Treatment in Allergic Rhinitis During the Pollen Season in Europe: A MASK-air Study.
Sousa-Pinto B, Costa EM, Vieira RJ, Klimek L, Czarlewski W, Pfaar O, Bedbrook A, Amaral R, Brussino L, Kvedariene V, Larenas-Linnemann DE, Iinuma T, Pham-Thi N, Regateiro FS, Taborda-Barata L, Ventura MT, Ansotegui IJ, Bergmann KC, Canonica GW, Cardona V, Cecchi L, Cherrez-Ojeda I, Cingi C, Cruz AA, Del Giacco S, Devillier P, Fokkens WJ, Gemicioglu B, Haahtela T, Ivancevich JC, Kuna P, Kraxner H, Laune D, Louis R, Makris M, Morais-Almeida M, Mösges R, Niedoszytko M, Papadopoulos NG, Patella V, Pereira AM, Reitsma S, Robles-Velasco K, Rouadi PW, Samolinski B, Sova M, Toppila-Salmi SK, Sastre J, Valiulis A, Yorgancioglu A, Zidarn M, Zuberbier T, Fonseca JA, Bousquet J; MASK‐air think tank. Sousa-Pinto B, et al. Clin Exp Allergy. 2025 Mar;55(3):226-238. doi: 10.1111/cea.70004. Epub 2025 Feb 16. Clin Exp Allergy. 2025. PMID: 39956639 Free PMC article.
Comparing allergic rhinitis treatments based on patient satisfaction: A MASK-air® study.
Vieira RJ, Sousa-Pinto B, Gil-Mata S, Bedbrook A, Brussino L, Maria Giuliano AF, Klimek L, Kvedariene V, Niedoszytko M, Pfaar O, Pham-Thi N, Samolinski B, Ventura MT, Zuberbier T, Fonseca JA, Bousquet J; MASK-air Think Tank. Vieira RJ, et al. J Allergy Clin Immunol Pract. 2025 Sep;13(9):2529-2531.e1. doi: 10.1016/j.jaip.2025.05.058. Epub 2025 Jun 6. J Allergy Clin Immunol Pract. 2025. PMID: 40484347 Free article. No abstract available.
102 results